コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 ricular-mass index, and greater reduction in urinary albumin excretion.
2 ced glomerular filtration rate and increased urinary albumin excretion.
3 r adjustment for clinical covariates such as urinary albumin excretion.
4 nce renal vascular integrity as reflected by urinary albumin excretion.
5 foot processes in the kidney glomerulus, and urinary albumin excretion.
6 trasound, ankle-brachial blood pressure, and urinary albumin excretion.
7 overlaps with genes controlling variation in urinary albumin excretion.
8 wed for 4 years with repeated assessments of urinary albumin excretion.
9 erally is assessed by measurement of GFR and urinary albumin excretion.
10 ient sFlt-1 mice also showed markedly higher urinary albumin excretion (467+/-74 versus 174+/-23 mug/
12 Here, we examined whether higher levels of urinary albumin excretion among African Americans contri
14 n in 13 type 1 diabetic subjects with normal urinary albumin excretion and 13 healthy volunteers.
15 brisentan attenuated the increases in BP and urinary albumin excretion and ameliorated endotheliosis
16 hat there is an association between elevated urinary albumin excretion and apolipoprotein B fraction
17 red the glomerular filtration rate (GFR) and urinary albumin excretion and assessed the prevalence of
18 ly overt manifestations, including increased urinary albumin excretion and decreased glomerular filtr
19 ssessed cross-sectional associations between urinary albumin excretion and dietary patterns and intak
20 iation was lost after further adjustment for urinary albumin excretion and eGFR [HR:1.15 (95% CI, 0.8
21 the frequency of a significant reduction in urinary albumin excretion and factors affecting such red
22 treatment with CTLA4-Ig prevented increased urinary albumin excretion and improved kidney pathology
23 /-1.2 vs 7.9+/-0.6 micromol/L p<0.01), while urinary albumin excretion and mesangial expansion were r
24 delay the onset and progression of increased urinary albumin excretion and reduced GFR in patients wi
26 tid ultrasound, ankle-brachial pressure, and urinary albumin excretion) and stratified by body mass i
27 nal function (glomerular filtration rate and urinary albumin excretion), and routine biochemistry sho
28 omerular filtration rate, renal plasma flow, urinary albumin excretion, and blood pressure were measu
29 lar filtration rate, serum creatinine level, urinary albumin excretion, and blood pressure; the rates
30 oponin-T, high-sensitive C-reactive protein, urinary albumin excretion, and cystatin-C had similar ri
31 ation of hypertension with serum creatinine, urinary albumin excretion, and ESRD in the United States
32 The rates of decline in the estimated GFR, urinary albumin excretion, and other secondary outcomes
33 imaging, we related arterial stiffness, GFR, urinary albumin excretion, and potential mediators, incl
34 sion, extracellular matrix accumulation, and urinary albumin excretion as well as NOX4 protein expres
36 o -0.4; P=0.003) but positively with 24-hour urinary albumin excretion (beta=0.11; 95% CI, 0.01 to 0.
37 ted that treatment with sTbetaRII.Fc reduced urinary albumin excretion by 36% at 4 weeks, 59% at 8 we
40 with type 1 diabetes indicates that elevated urinary albumin excretion does not imply inexorably prog
42 nuria, indicated by repeated measurements of urinary albumin excretion (estimated on the basis of alb
49 ich was defined as a 50 percent reduction in urinary albumin excretion from one two-year period to th
50 betic Cav2.2(-/-) mice significantly reduced urinary albumin excretion, glomerular hyperfiltration, b
51 00 mg/kg body wt/d) in the drinking water on urinary albumin excretion, glomerular transforming growt
52 anced by lack of both B1R and B2R, including urinary albumin excretion, glomerulosclerosis, glomerula
53 s included progression to overt proteinuria (urinary albumin excretion > or = 300 mg/d) in half of th
55 d statistical significance with variation in urinary albumin excretion in family members with type 2
59 -B-type natriuretic peptide, troponin-T, and urinary albumin excretion, increasing model accuracy to
60 m and long-term benefits of empagliflozin on urinary albumin excretion, irrespective of patients' alb
65 d to a normoalbuminuric or macroalbuminuric (urinary albumin excretion <30 mg/24 hours and >300 mg/24
66 uria may occur in diabetes and how increased urinary albumin excretion may be indicative of CV risk.
69 btained and are reliable indices of elevated urinary albumin excretion (microalbuminuria) in IDDM.
70 inhibitor type 1), and microvascular damage (urinary albumin excretion; n=2673) to incident AF (n=209
71 ase-line blood pressure predicted increasing urinary albumin excretion (P=0.006), and higher base-lin
72 in excretion (P=0.006), and higher base-line urinary albumin excretion predicted a decline in the glo
75 correlation between plasma PK levels and the urinary albumin excretion rate (AER) was also observed (
76 survival studies in NIDDM, microalbuminuria (urinary albumin excretion rate 20-200 microg/min) predic
77 to high-density lipoprotein cholesterol, and urinary albumin excretion rate and with the mean glycosy
79 poproteins, glycosylated hemoglobin, and the urinary albumin excretion rate were measured in a centra
80 t smoking, preexisting CHD, and high initial urinary albumin excretion rate were risk factors for the
81 dex, higher von Willebrand factor levels and urinary albumin excretion rate, hypertension, and smokin
84 itor, reduced systolic blood pressure (SBP), urinary albumin excretion, segmental sclerosis, podocyte
94 -0.57 g per square meter per year, P<0.001); urinary albumin excretion was reduced by 3.77% with the
95 Such modification was also observed when urinary albumin excretion was stratified into normo-, mi
96 sive, nondiabetic individuals, low levels of urinary albumin excretion well below the current microal
97 rular capillary basement membrane width, and urinary albumin excretion were increased in diabetic rat
98 Histologic evidence of glomerular injury and urinary albumin excretion were more pronounced in double
101 xplain, in part, the association of elevated urinary albumin excretion with cardiovascular disease ri
102 protein B fractions modified associations of urinary albumin excretion with incident cardiovascular d
103 termined whether the association of elevated urinary albumin excretion with incident cardiovascular e
104 LDO pod GC-A cKO mice demonstrated increased urinary albumin excretion with marked mesangial expansio
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。